Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.
Latest updates to the Prevent Early Onset AD Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about a lapse in government funding was added, including that the NIH Clinical Center is open. The page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.3%
- Check11 days agoChange DetectedAdded a Show glossary feature and new metadata fields: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed the old fields Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%
- Check47 days agoChange DetectedThe Locations section was updated to include additional trial sites across multiple countries and regions (e.g., Alabama, California, New South Wales, Tokyo-To). This expands the list of accessible sites for the study.SummaryDifference2%
- Check69 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no other visible changes to the page content.SummaryDifference0.0%
- Check76 days agoChange DetectedThese changes are minor editorial updates related to the PubMed publication text and the revision version numbers, and do not affect the core study details or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.